Course Outline:
Identification of the High-Risk Patient and Risk Assessment Models
Ruth Heisey, MD
Exercise- How Much is Enough?
Sarah Bazzetta, MMS, MAS, PA-C
Complexities When Ordering Germline Cancer Genetic Panel Testing
Padma S. Rajagopal, MD, MPH
Break
PRS- Stratification in Hereditary and Familial Patients
Sandhya Pruthi, MD
Review and Controversies of Current Genetic Testing Guidelines
Padma S. Rajagopal, MD, MPH
Controversies in Ovarian Cancer Screening and What’s on The Horizon
Shannel R. Adams, MD
Genetic Counselors and Future Directions in Genetic Counseling: Telehealth and IT
Sara Pirzadeh-Miller, MS, CGC
Break
Challenging High Risk Cases
Moderators: Holly J. Pederson, MD & Sandhya Pruthi, MD with
Asha Bhatt, MD; Erin Hofstatter, MD; Jennifer K. Plicta MD;
Sarah Bazzetta, MMS, MAS, PA-C; Carrie Langstraat, MD; Ruth Heisey, MD
The Evidence Behind Preventive Supplements – Vitamin D,
Omega 3 and Aspirin
Sarah Bazzetta, MMS, MAS, PA-C
Novel Breast Imaging Technologies for the High-Risk Patient - Are Mammograms a Thing of the Past?
Asha Bhatt, MD
Break
Bilateral Mastectomies Without “The Gene”: When & Why?
Jennifer K. Plicta, MD
Controversies in Risk Reducing Pelvic Surgery
(Salpingectomy +/- Uterus and Timing)
Carrie Langstraat, MD
Hormone Therapy in BRCA patients
Erin Hofstatter, MD
Course Ends
